• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Dechra Pharmaceuticals PLC

DPHAF:US

Ticker Delisted

Snapshot for Dechra Pharmaceuticals PLC (DPHAF)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for DPHAF

No chart data available.
  • DPHAF:US
  • 1M
  • 1Y
0.0000
Interactive DPHAF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DPHAF

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (06/2015) 0.3820
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (GBp) 4.7500
Dividend Ex-Date 03/12/2014
5 Year Dividend Growth 20.68%
Next Earnings Announcement 02/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DPHAF

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for DPHAF

Dechra Pharmaceuticals PLC is an international pharmaceutical business focused on the veterinary market, with its key area of specialisation being the development and marketing of companion animal products. The Company Operates under four segments: European Pharmaceuticals, US Pharmaceuticals, Product Development and Services.

Ian David PageCEO/Executive DirectorAnne-Francoise NesmesCFO/Executive Director
Mike EldredPresident:US OperationsTony GriffinMng Dir:Veterinary Products/Exec Dir
More Company Profile & Key Executives for DPHAF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • DPHAF News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil